Mucolab: Vertex and the Société Française de Mucoviscidose (Cystic Fibrosis French Society) choose Ad Scientiam
11 décembre 2020
The Ad Scientiam team is proud to announce this new partnership with the Société Française de la Mucoviscidose (Cystic Fibrosis French Society) and Vertex Pharmaceuticals.
This ambitious innovation project aims to improve the follow-up of patients with cystic fibrosis at home, thanks to new respiratory digital biomarkers.
This collaboration reinforces Ad Scientiam’s commitment to creating new assessment standards, serving patients and healthcare professionals.
English 
French